Human papillomavirus infection in the etiology of laryngeal carcinoma

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 12, Issue 2, 2004, Pages 88-92

  Hobbs, Christopher G L ^a   Birchall, Martin A ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b Laryngeal Research Group   (United Kingdom)

Author keywords

Human papillomavirus; Laryngeal carcinoma; Laryngeal papilloma

Indexed keywords

VIRUS DNA;

ALCOHOL CONSUMPTION; CANCER EPIDEMIOLOGY; CARCINOGENESIS; DISEASE ASSOCIATION; HEAD AND NECK CANCER; HUMAN; IRRADIATION; LARYNX CANCER; LARYNX CARCINOMA; LARYNX PAPILLOMATOSIS; MALIGNANT TRANSFORMATION; MOLECULAR BIOLOGY; MUCOSAL IMMUNITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; VACCINATION; VIRUS INFECTION; WART VIRUS;

HUMANS; IMMUNITY, CELLULAR; LARYNGEAL NEOPLASMS; LARYNX; MUCOUS MEMBRANE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS;

EID: 1842590593     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-200404000-00006     Document Type: Review

References (37)

1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Human Papillomaviruses, vol. 64. Lyon, France: International Agency for Research on Cancer, IARC Scientific Publications; 1995.
2. Koutsky LA, Ault KA, Wheeler CM, et al.: A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002, 347:1645-1651. Level 1b evidence is reported that shows a reduced incidence of both HPV-16 infection and HPV-16-related cervical intraepithelial neoplasia after HPV-16 vaccination.
3. Mork J, Lie AK, Glattre E, et al.: Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001, 344:1125-1131.
4. Lack EE, Vawter GF, Smith HG, et al.: Immunohistochemical localisation of human papillomavirus in squamous papillomas of the larynx. Lancet 1980, ii:592.
5. Abramson AL, Brandsma J, Steinberg B, et al.: Verrucous carcinoma of the larynx. Possible human papillomavirus etiology. Arch Otolaryngol 1985, 111:709-715.
6. Talamini R, Bosetti C, La Vecchia C, et al.: Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study. Cancer Causes Control 2002, 13:957-964. This large, multicenter study confirms the huge multiplicative risk of heavy alcohol consumption and heavy cigarette smoking.
7. Agudelo D, Quer M, Leon X, et al.: Laryngeal carcinoma in patients without a history of tobacco and alcohol use. Head Neck 1997, 19:200-204.
8. Wight R, Paleri V, Arullendran P: Current theories for the development of nonsmoking and nondrinking laryngeal carcinoma. Curr Opin Otolaryngol Head Neck Surg 2003, 11:73-77.
9. Hagensee ME: Infection with human papillomavirus: update on epidemiology, diagnosis, and treatment. Curr Infect Dis Rep 2000, 2:18-24.
10. Fischer M, von Winterfeld F: Evaluation and application of a broad-spectrum polymerase chain reaction assay for human papillomaviruses in the screening of squamous cell tumours of the head and neck. Acta Otolaryngol 2003, 123:752-758.
11. Walboomers JM, Jacobs MV, Manos MM, et al.: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
12. Bosch FX, Munoz N: The viral etiology of cervical cancer. Virus Res 2002, 89:183-190.
13. Clifford GM, Smith JS, Aguado T, et al.: Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003, 89:101-105.
14. Aaltonen LM, Rihkanen H, Vaheri A: Human papillomavirus in larynx. Laryngoscope 2002, 112:700-707.
15. Nunez DA, Astley SM, Lewis FA, et al.: Human papilloma viruses: a study of their prevalence in the normal larynx. J Laryngol Otol 1994, 108:319-320.
16. Brandsma JL, Abramson AL: Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg 1989, 115:621-625.
17. Garcia-Milian R, Hernandez H, Panade L, et al.: Detection and typing of human papillomavirus DNA in benign and malignant tumours of laryngeal epithelium. Acta Otolaryngol 1998, 118:754-758.
18. Nishioka S, Fukushima K, Nishizaki K, et al.: Human papillomavirus as a risk factor for head and neck cancers-a case-control study. Acta Otolaryngol Suppl 1999, 540:77-80.
19. Lie ES, Engh V, Boysen M, et al.: Squamous cell carcinoma of the respiratory tract following laryngeal papillomatosis. Acta Otolaryngol 1994, 114:209-212.
20. Go C, Schwartz MR, Donovan DT: Molecular transformation of recurrent respiratory papillomatosis: viral typing and p53 overexpression. Ann Otol Rhinol Laryngol 2003, 112:298-302. This is an interesting case series that emphasizes the difficulty of managing malignant transformation in this disease.
21. Renan MJ: How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinog 1993, 7:139-146.
22. Rabkin CS, Biggar RJ, Melbye M, et al.: Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors. Am J Epidemiol 1992, 136:54-58.
23. Dillner J, Knekt P, Schiller JT, et al.: Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma. BMJ 1995, 311:1346.
24. Herrero R: Human papillomavirus and cancer of the upper aerodigestive tract. J Natl Cancer Inst Monogr 2003, 47-51. This is an excellent and concise review of the current evidence on HPV and its possible role in laryngeal and oropharyngeal cancer. It highlights the limitations of studies so far and provides useful suggestions for further research.
25. Rees L, Birchall MA, Bailey M, et al.: A systematic review of case-control studies of human papillomavirus (HPV) infection in laryngeal squamous cell carcinoma. Clin Otolaryngol 2004, In press.
26. Smith EM, Summersgill KF, Allen J, et al.: Human papillomavirus and risk of laryngeal cancer. Ann Otol Rhinol Laryngol 2000, 109:1069-1076.
27. Nadal A, Cardesa A: Molecular biology of laryngeal squamous cell carcinoma. Virchows Arch 2003, 442:1-7. This is a good summary listing the mechanisms of transformation and progression in laryngeal cancer.
28. Ha PK, Califano JA III: The molecular biology of laryngeal cancer. Otolaryngol Clin North Am 2002, 35:993-1012.
29. Balz V, Scheckenbach K, Gotte K, et al.: Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens. Cancer Res 2003, 63:1188-1191. In this series, the laryngeal cases show a much higher level of p53 mutation than previous studies. The authors propose that p53 inactivation is an obligatory step.
30. Gasco M, Crook T: The p53 network in head and neck cancer. Oral Oncol 2003, 39:222-231.
31. Vielba R, Bilbao J, Ispizua A, et al.: p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx. Laryngoscope 2003, 1 13:167-172.
32. Du J, Chen GG, Vlantis AC, et al.: The nuclear localization of NFkappaB and p53 is positively correlated with HPV16 E7 level in laryngeal squamous cell carcinoma. J Histochem Cytochem 2003, 51:533-539.
33. Gillison ML, Shah KV: Role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr 2003, 57-65.
34. Almadori G, Galli J, Cadoni G, et al.: Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: biologic function and clinical significance. Head Neck 2002, 24:597-604.
35. Venuti A, Manni V, Morello R, et al.: Physical state and expression of human papillomavirus in laryngeal carcinoma and surrounding normal mucosa. J Med Virol 2000, 60:396-402.
36. Wank R, Meulen JT, Luande J, et al.: Cervical intraepithelial neoplasia, cervical carcinoma, and risk for patients with HLA-DQB1*0602,* 301,*0303 alleles. Lancet 1993, 341:1215.
37. Gelder CM, Williams OM, Hart KW, et al.: HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis. J Virol 2003, 77:1927-1939. This study found a pointer toward why certain patients are susceptible to laryngeal papillomatosis and probably, therefore, HPV-associated malignant transformation. This is an important area of future research.